Steris (STE) EBIT (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.96% |
| Dec 31, 2025 | 2.78% |
| Sep 30, 2025 | 8.05% |
| Jun 30, 2025 | 13.81% |
| Mar 31, 2025 | -11.89% |
| Dec 31, 2024 | 11.65% |
| Sep 30, 2024 | 18.44% |
| Jun 30, 2024 | -15.81% |
| Mar 31, 2024 | -2.71% |
| Dec 31, 2023 | 18.23% |
| Sep 30, 2023 | -3.14% |
| Jun 30, 2023 | -73.57% |
| Mar 31, 2023 | 292.19% |
| Dec 31, 2022 | 162.27% |
| Sep 30, 2022 | -293.45% |
| Jun 30, 2022 | 9.95% |
| Mar 31, 2022 | -29.01% |
| Dec 31, 2021 | 74.19% |
| Sep 30, 2021 | 713.34% |
| Jun 30, 2021 | 6,920.95% |
| Mar 31, 2021 | -100.14% |
| Dec 31, 2020 | 4.08% |
| Sep 30, 2020 | 21.97% |
| Jun 30, 2020 | 11,990.86% |
| Sep 30, 2019 | 15.12% |
| Jun 30, 2019 | -21.61% |
| Mar 31, 2019 | 101.82% |
| Dec 31, 2018 | -34.71% |
| Sep 30, 2018 | 12.87% |
| Jun 30, 2018 | -67.70% |